BMP-2-embedded atelocollagen scaffold for tissue-engineered cartilage cultured in the medium containing insulin and Triiodothyronine-A new protocol for 3D in vitro culture of human chondrocytes
BMP-2-embedded atelocollagen scaffold for tissue-engineered cartilage cultured in the medium containing insulin and Triiodothyronine-A new protocol for 3D in vitro culture of human chondrocytes
复制标题
BMP-2 嵌入的去端胶原支架用于在含有胰岛素和三碘甲腺原氨酸的培养基中培养的组织工程软骨 - 人软骨细胞 3D 体外培养的新方案
DOI:
10.1089/ten.tec.2011.0217
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
et al.
中科院分区:
文献类型:
--
作者:
Ko EC;et al.
When the chondrocytes are isolated from the native cartilage and proliferate in vitro, they soon lose their original ability to express glycosaminoglycan (GAG) and type II collagen, which is termed dedifferentiation, or decrease cell viability. We first examined in vitro cartilage regeneration of tissue-engineered pellets that consisted of human auricular chondrocytes and atelocollagen and that were incubated in vitro under stimulation with bone morphogenetic protein-2 (BMP-2), insulin, and T3. We then examined the administration of those growth factors into the scaffold or in the medium and explored the possibility that the atelocollagen, the hydrogel scaffold of the chondrocytes, may function for drug delivery of the factors. BMP-2 in the atelocollagen with the supplement of insulin and T3 in the medium could not only produce a greater GAG matrix in a shorter period but also sustain cell viability with lower mortality. The insulin in the medium could be better administered only for 2 weeks, rather than 3 weeks, which would save time and cost, hence shortening the in vitro culture of chondrocytes. Our protocol of mixing BMP-2 into the atelocollagen with the supplement of insulin and T3 hormone might provide a new insight into the development of tissue engineering in chondrogenesis.